Form 4: Kimberly-Clark Executive Andrew Drexler Reports Stock Option Exercise and Share Transactions
SEC Form 4 Filing
Andrew Drexler, Vice President and Controller of Kimberly-Clark, reports exercising stock options and selling shares to cover tax obligations.
Summary
- Andrew Drexler, a Vice President and Controller at Kimberly-Clark Corp, filed a Form 4 detailing changes in beneficial ownership.
- On February 28, 2025, Drexler exercised stock options to acquire 10,838 shares of common stock at a price of $132.63.
- He also received 7,389 shares of common stock from vested performance-based restricted share units.
- Drexler disposed of 10,838 shares at $141 and surrendered 2,222 shares to cover tax obligations at $142.01.
- Following these transactions, Drexler directly owns 7,720 shares of common stock.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and does not indicate any significant positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted share units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices are typical for such arrangements.
- Similar filings are regularly made by executives at comparable companies like Procter & Gamble (PG) and Unilever (UL).
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 04/29/2021 | Date of grant for 10,838 stock options exercisable until 04/29/2031 at a price of $132.63. |
| 04/26/2022 | Date of grant for 8,263 stock options exercisable until 04/26/2032 at a price of $139.18. |
| 02/28/2025 | Date of stock option exercise, vesting of restricted share units, and share sales. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
| 04/29/2031 | Expiration date for 10,838 stock options granted on 04/29/2021. |
| 04/26/2032 | Expiration date for 8,263 stock options granted on 04/26/2022. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.